Innovation

Kristy Sinkfield, MEd, left, hosted a panel discussion with Mamie Williams, MPH, MSN, FNP-BC, Mary Duvanich, MSN, MMHC, Novonda Lilly, and Marques Bradshaw, MD, during Strategy Share 2022. The discussion was on promoting diversity, equity and inclusion throughout VUMC. (photo by Erin O. Smith)

Strategy Share 2022 spotlights VUMC’s successes in making health care personal

Strategy Share 2022 was centered on initiatives and programs that advance the three components of the Medical Center’s Strategic Directions: Making Diversity and Inclusion Intentional, Design for Patients and Families, and Discover, Learn and Share.

VUMC to lead AI ethics core for NIH project

Vanderbilt researchers will lead and comprise the greater part of an artificial intelligence research ethics core for a National Institutes of Health (NIH) program called Bridge to Artificial Intelligence, or Bridge2AI.

Study tests drug to illuminate cancer during surgery

A Vanderbilt study is testing drugs that provide a targeted fluorescent dye that clings to and illuminates cancer.

Panoramic ‘DNA’ podcast Season 3 explores elements of well-being

Shown here is the research team that discovered monoclonal antibodies that protect against COVID-19 in high-risk individuals.

COVID antibody research conducted at VUMC lands national award

A long-acting antibody combination discovered at Vanderbilt University Medical Center that protects against COVID-19 in high-risk individuals has received a gold medal in the 2022 R&D 100 awards program announced Aug. 22 by R&D World Magazine.

Say hello. ‘DNA’ podcast series coming Fall 2022

Be one of the first to preview the all-new ‘Vanderbilt Health DNA: Discoveries in Action’ podcast series. #ListenDNA.

1 2 3 4 5 6 7